Cannabix Technologies Inc. (CSE:BLO)
Canada · Delayed Price · Currency is CAD 0.4500
-0.0100 (-2.17%)
Nov 3, 2026, 10:52 AM EST
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of CAD 55.43 million as of November 3, 2026. It is the 31,532nd most valuable company in the world and the 888th biggest in Canada. Its market cap has decreased by 11.96% in one year.
Market Cap
55.43M
Enterprise Value
54.42M
Revenue
n/a
Global Rank
Country Rank
#888 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 574.76K to 55.43M, an increase of 9,543.96%. That is a compound annual growth rate of 42.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 51.12M | -27.21% |
| Dec 31, 2025 | 70.22M | 90.58% |
| Dec 31, 2024 | 36.85M | 79.34% |
| Dec 29, 2023 | 20.55M | -44.62% |
| Dec 30, 2022 | 37.10M | -39.81% |
| Dec 31, 2021 | 61.64M | -34.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 335.37M |
| Vector Science and Therapeutics | 308.04M |
| Theralase Technologies | 55.89M |
| Perimeter Medical Imaging AI | 27.62M |
| Cheelcare | 27.05M |
| Ventripoint Diagnostics | 15.43M |
| Conavi Medical | 15.18M |
| Frequency Exchange | 15.03M |